Novel artificial intelligence platform for drug development and personalized medicine
Our Services
HEALTH CARE ONCOLOGY WORKFLOW
HEALTH CARE ONCOLOGY WORKFLOW
- FDA Approved Drugs
- Medical indications
- Pharmacology toxicities
- Drugs interactions
- Ongoing clinical studies
- European and American guidelines
- Molecular Biomarkers for personalized medicine
- Real World Data
- Best workflow to reduce medical effort
PRECISION MEDICINE SOLUTIONS
PRECISION MEDICINE SOLUTIONS
- Genomic Molecular Alterations
- Evaluation of oncogenic molecular panels
- Druggable vulnerabilities
- Targered agents
- Therapeutic opportunities
- Drug combinations
- Ongoing clinical studies
- Identification of best treatment based on propietary algorithms
BIOMARKER AND DRUG DEVELOPER
BIOMARKER AND DRUG DEVELOPER
- Genomic molecular alterations
- Potential target inhibition
- Druggable vulnerabilities
- Current clinical development
- Competitive landscape
- Target population and indication
- Evaluation of attrition rate
- Pharma intelligent
- Identification of best clinical development
What we do
This platform uses data from different sources including molecular alterations, scientific results, clinical trials, combinations of compounds, described efficacy, competitive landscape, in addition to side effects or potential interactions, to provide the user with all relevant data in a customized manner, without the necessity to obtain this information through complex consulting dossiers.
In addition, we are developing algorithms that can help to predict the success of a new pharmacological compound through the identification of unmet necessities, empty areas, potential side effects or combinations that would not reach the clinical setting, as well as crowded sectors or areas for business development.
Request an online test
We would be happy to show you our platform.
FDA Approved Drugs
Investigational Drugs
Tumor Types
Genes
Biomarkers
Drug Interactions
Meet Sarah…
Meet Sarah. She's a scientist who does research on medications that treat cancer. Now Sarah's a busy woman, so she doesn't have the 21 hours a day it would take to read and process all the new information that comes out about cancer everyday. But luckily for Sarah,...
Pre-seed round
CancerAppy raised a pre-seed round of € 120K. In the middle of the Covid pandemic and with the lockdown active, the CancerAppy team, led by its CEO Luis Martín, closed the negotiations for a pre-seed round with a group of local investors. This allows us to move faster...
Venture on the Road
Part of our team was enjoying "Venture on the Road" at innolab Bilbao.